Journal of the American Pharmacists Association最新文献

{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 1","pages":"Article 102966"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146629535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 1","pages":"Article 102947"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146629560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 1","pages":"Article 102997"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146629565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 1","pages":"Article 102932"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146629570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 1","pages":"Article 102930"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146629572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 1","pages":"Article 102940"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146629573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 1","pages":"Article 102985"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146629587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 1","pages":"Article 102984"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146629601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Safety and efficacy of budesonide/glycopyrrolate/formoterol fumarate compared with glycopyrrolate/formoterol fumarate for the treatment of COPD: A systematic review and meta-analysis","authors":"Piyush Thathera,&nbsp;Aakriti Garg,&nbsp;Shaista Ahmed,&nbsp;Mohd Ashif Khan","doi":"10.1016/j.japh.2025.102906","DOIUrl":"10.1016/j.japh.2025.102906","url":null,"abstract":"<div><h3>Background</h3><div>Chronic obstructive pulmonary disease (COPD) is a progressive illness characterized by persistent respiratory symptoms and restricted airflow, often owing to smoking and prolonged exposure to environmental irritants. COPD affects the pulmonary vasculature, lung parenchyma, and airways, leading to structural abnormalities such as emphysema. This study compares the safety and effectiveness of budesonide/glycopyrrolate/formoterol fumarate (BGF) metered-dose inhaler (MDI) with glycopyrrolate/formoterol fumarate (GFF) MDI in patients with moderate to severe COPD, focusing on adverse events and forced expiratory volume in 1 second (FEV1).</div></div><div><h3>Methods</h3><div>A comprehensive literature search was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The search encompassed databases such as PubMed, MEDLINE, <span><span>ClinicalTrials.gov</span><svg><path></path></svg></span>, Cochrane Library, ScienceDirect, Web of Science, and Google Scholar up to April 2024. Search terms included “COPD,” “dual therapies,” “triple therapies,” “LABA,” “LAMA,” “BGF MDI,” “FEV₁,” and “COPD exacerbation.” Only English-language randomized controlled trials involving patients aged 40-80 years who were current or former smokers with confirmed COPD were included. In addition, reference lists of included studies were screened. Study quality was assessed using the Cochrane Risk of Bias 2.0 tool.</div></div><div><h3>Results</h3><div>Through an initial literature review, we obtained 4022 articles, 4 of which were included in the current study. Results showed a statistically significant rise in FEV1 with BGF MDI compared with GFF MDI at 4, 24, and 52 weeks. At 52 weeks, the pooled mean difference in FEV1 was 46.48 mL (95% CI 25.26–67.71). Safety profiles were similar, with adverse events such as nasopharyngitis and upper respiratory tract infections observed in both treatments.</div></div><div><h3>Conclusion</h3><div>BGF MDI significantly improves lung function compared with GFF MDI in moderate to severe COPD and has a comparable safety profile. Further large-scale studies are needed to confirm long-term safety.</div></div>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 1","pages":"Article 102906"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144986486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Creation of the CAP center: Advancing pharmacy practice through implementation science integration","authors":"Elizabeth Skoy,&nbsp;Heidi Eukel,&nbsp;Brody Maack,&nbsp;Lisa Nagel,&nbsp;Mark Strand,&nbsp;Amy Werremeyer","doi":"10.1016/j.japh.2025.102961","DOIUrl":"10.1016/j.japh.2025.102961","url":null,"abstract":"<div><h3>Background</h3><div>Community pharmacies are increasingly recognized for their potential to deliver innovative patient care services. However, implementation of these services is often hindered by barriers. Implementation science (IS) offers a framework to address these challenges, yet its application in pharmacy practice remains limited. North Dakota is a rural state with one school of pharmacy and a unique pharmacy landscape.</div></div><div><h3>Objectives</h3><div>To describe the creation and impact of the Center for Collaboration and Advancement in Pharmacy (CAP Center), designed to support pharmacies in implementing and sustaining innovative patient care services using IS frameworks such as Practical, Robust Implementation and Sustainability Model and the Reach, Effectiveness, Adoption, Implementation, and Maintenance Model.</div></div><div><h3>Practice description</h3><div>Launched in 2021, the CAP Center was created by faculty and is focused on the principles of IS to increase uptake and sustainability of pharmacy services to meet patient demand and improve population health.</div></div><div><h3>Practice innovation</h3><div>The CAP Center operates on 4 core principles: Program and Implementation, Education and Training, Coaching and Support, and Data and Outcomes. It uses the principles of IS to provide guidance, resources, and evaluation strategies to pharmacy teams, by supporting projects from conception through sustainability. The Center's application of IS and the core principles allow for successful implementation of pharmacy services.</div></div><div><h3>Evaluation methods</h3><div>CAP Center engagement is assessed through metrics such as continuing education credits offered, pharmacy participation, symposium attendance, and project volume. Individual projects are evaluated on adherence to IS principles and implementation outcomes.</div></div><div><h3>Results</h3><div>Since inception, 93% of North Dakota's community pharmacies have engaged with the CAP Center. Notable projects have demonstrated successful application of IS frameworks, leading to sustainable service delivery and improved patient care.</div></div><div><h3>Conclusion</h3><div>The CAP Center exemplifies how IS can be operationalized in pharmacy practice to aid in pharmacy program implementation and improve health outcomes. Its model may serve as a blueprint for similar efforts to expand pharmacy services nationwide.</div></div>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 1","pages":"Article 102961"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145423854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}